Deanna Jones serves as the Director of Bioprocess Technology Solutions at Merck, where she leverages her extensive expertise in pharmaceuticals to drive innovation and operational excellence in vaccine and biologics manufacturing. With a robust background in drug product and drug substance operations, Deanna has established...
Deanna Jones serves as the Director of Bioprocess Technology Solutions at Merck, where she leverages her extensive expertise in pharmaceuticals to drive innovation and operational excellence in vaccine and biologics manufacturing. With a robust background in drug product and drug substance operations, Deanna has established herself as a pivotal leader within the site technical operations department. Her role involves not only managing a talented team of nine professionals but also contributing to the site leadership team, where she plays a critical role in shaping business strategies that align with the organization’s growth objectives.
Deanna’s proficiency in single-use systems and design, coupled with her deep understanding of filtration and change control processes, enables her to ensure that raw materials and components consistently meet stringent product and process requirements. Her commitment to supplier technical management fosters strong partnerships with vendors, ensuring that all materials comply with Good Manufacturing Practices (GMP) and U.S. Food and Drug Administration (FDA) regulations.
In her current position, Deanna is actively involved in several key projects aimed at enhancing operational efficiency and expanding product lines. Her strategic vision encompasses identifying opportunities for revenue growth, optimizing technology transfer processes, and implementing best practices across multi-site operations. Deanna’s technical leadership and organizational skills have been instrumental in navigating the complexities of biologics manufacturing, making her a respected figure in the industry and a driving force behind Merck's commitment to delivering high-quality vaccines and therapeutics.
